# OnCo record rgt-61159 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/rgt-61159/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "rgt-61159" ;
  schema:name "RGT-61159"@en ;
  schema:description "RGT-61159 is an experimental small molecule from Rgenta Therapeutics, in phase 1 trials for relapsed or refractory adenoid cystic carcinoma and colorectal cancer."@en ;
  schema:url <https://onco.cc/drugs/rgt-61159/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.prnewswire.com/news-releases/rgenta-therapeutics-announces-first-patients-dosed-in-phase-1ab-clinical-trial-of-rgt-61159-an-oral-small-molecule-targeting-myb-in-adenoid-cystic-carcinoma-acc-and-colorectal-cancer-crc-302269345.html>, <https://www.rgentatx.com/news>, <https://clinicaltrials.gov/study/NCT06462183>, <https://clinicaltrials.gov/search?intr=RGT-61159> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule (oral RNA splicing modulator)" ;
  onco:cancers <https://onco.cc/cancers/adenoid-cystic-carcinoma/>, <https://onco.cc/cancers/colorectal/> ;
  onco:targets <https://onco.cc/targets/myb/> ;
  onco:companies <https://onco.cc/companies/rgenta-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06462183/> .